Using a Bayesian adaptive phase II trial design to test multiple genetic-marker-directed drugs in the National Lung Matrix Trial

  • Billingham, L. (Invited speaker)
  • Kristian Brock (Invited speaker)
  • Laura Llewellyn (Invited speaker)
  • Sanjay Popat (Invited speaker)
  • Gary Middleton (Invited speaker)

Activity: Academic and Industrial eventsConference, workshop or symposium

Description

Oral presentation of paper from Journal of Thoracic Oncology 2015, 10 (9) Supp2: S372, MINI29.14
Period6 Sep 20159 Sep 2015
Event title16th World Conference on Lung Cancer: Meta-Analyses and Trial Conduct session
Event typeConference
LocationDenver, United StatesShow on map
Degree of RecognitionInternational